These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12947001)

  • 1. Thrombospondin 1 as a scavenger for matrix-associated fibroblast growth factor 2.
    Margosio B; Marchetti D; Vergani V; Giavazzi R; Rusnati M; Presta M; Taraboletti G
    Blood; 2003 Dec; 102(13):4399-406. PubMed ID: 12947001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 140-kilodalton antiangiogenic fragment of thrombospondin-1 binds to basic fibroblast growth factor.
    Taraboletti G; Belotti D; Borsotti P; Vergani V; Rusnati M; Presta M; Giavazzi R
    Cell Growth Differ; 1997 Apr; 8(4):471-9. PubMed ID: 9101093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scatter factor binds to thrombospondin and other extracellular matrix components.
    Lamszus K; Joseph A; Jin L; Yao Y; Chowdhury S; Fuchs A; Polverini PJ; Goldberg ID; Rosen EM
    Am J Pathol; 1996 Sep; 149(3):805-19. PubMed ID: 8780385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiproliferative and antitumor activities of D-reverse peptides derived from the second type-1 repeat of thrombospondin-1.
    Guo NH; Krutzsch HC; Inman JK; Shannon CS; Roberts DD
    J Pept Res; 1997 Sep; 50(3):210-21. PubMed ID: 9309585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of angiogenesis by thrombospondin-1 is mediated by 2 independent regions within the type 1 repeats.
    Iruela-Arispe ML; Lombardo M; Krutzsch HC; Lawler J; Roberts DD
    Circulation; 1999 Sep; 100(13):1423-31. PubMed ID: 10500044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor-2 binding to the thrombospondin-1 type III repeats, a novel antiangiogenic domain.
    Margosio B; Rusnati M; Bonezzi K; Cordes BL; Annis DS; Urbinati C; Giavazzi R; Presta M; Ribatti D; Mosher DF; Taraboletti G
    Int J Biochem Cell Biol; 2008; 40(4):700-9. PubMed ID: 17996481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of multiple heparin binding growth factors with neuropilin-1 and potentiation of the activity of fibroblast growth factor-2.
    West DC; Rees CG; Duchesne L; Patey SJ; Terry CJ; Turnbull JE; Delehedde M; Heegaard CW; Allain F; Vanpouille C; Ron D; Fernig DG
    J Biol Chem; 2005 Apr; 280(14):13457-64. PubMed ID: 15695515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor signaling pathway in endothelial cells is activated by BMPER to promote angiogenesis.
    Esser JS; Rahner S; Deckler M; Bode C; Patterson C; Moser M
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):358-67. PubMed ID: 25503991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of hepatocyte growth factor/scatter factor (HGF/SF) on fibroblast growth factor-2 (FGF-2) levels in external auditory canal cholesteatoma (EACC) cell culture.
    Naim R; Chang RC; Sadick H; Hormann K
    In Vivo; 2005; 19(3):599-603. PubMed ID: 15875782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules.
    Bashkin P; Doctrow S; Klagsbrun M; Svahn CM; Folkman J; Vlodavsky I
    Biochemistry; 1989 Feb; 28(4):1737-43. PubMed ID: 2541764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of bovine endothelial cells to FGF-2 and VEGF is dependent on their site of origin: Relevance to the regulation of angiogenesis.
    Cavallaro U; Tenan M; Castelli V; Perilli A; Maggiano N; Van Meir EG; Montesano R; Soria MR; Pepper MS
    J Cell Biochem; 2001; 82(4):619-33. PubMed ID: 11500940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial cell proliferation regulated by cytokines modulates thrombospondin-1 secretion into the subendothelium.
    Loganadane LD; Berge N; Legrand C; Fauvel-Lafève F
    Cytokine; 1997 Oct; 9(10):740-6. PubMed ID: 9344505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombospondins I and II messenger RNA expression in lung carcinoma: relationship with p53 alterations, angiogenic growth factors, and vascular density.
    Fontanini G; Boldrini L; Calcinai A; Chinè S; Lucchi M; Mussi A; Angeletti CA; Basolo F; Bevilacqua G
    Clin Cancer Res; 1999 Jan; 5(1):155-61. PubMed ID: 9918214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Internalization but not binding of thrombospondin-1 to low density lipoprotein receptor-related protein-1 requires heparan sulfate proteoglycans.
    Wang S; Herndon ME; Ranganathan S; Godyna S; Lawler J; Argraves WS; Liau G
    J Cell Biochem; 2004 Mar; 91(4):766-76. PubMed ID: 14991768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation.
    Zhang YW; Su Y; Volpert OV; Vande Woude GF
    Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12718-23. PubMed ID: 14555767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional changes in the conformation of thrombospondin-1 during complexation with fibronectin or heparin.
    Dardik R; Lahav J
    Exp Cell Res; 1999 May; 248(2):407-14. PubMed ID: 10222132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syndecan-4 contributes to endothelial tubulogenesis through interactions with two motifs inside the pro-angiogenic N-terminal domain of thrombospondin-1.
    Nunes SS; Outeiro-Bernstein MA; Juliano L; Vardiero F; Nader HB; Woods A; Legrand C; Morandi V
    J Cell Physiol; 2008 Mar; 214(3):828-37. PubMed ID: 17879962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-peptidic thrombospondin-1 mimics as fibroblast growth factor-2 inhibitors: an integrated strategy for the development of new antiangiogenic compounds.
    Colombo G; Margosio B; Ragona L; Neves M; Bonifacio S; Annis DS; Stravalaci M; Tomaselli S; Giavazzi R; Rusnati M; Presta M; Zetta L; Mosher DF; Ribatti D; Gobbi M; Taraboletti G
    J Biol Chem; 2010 Mar; 285(12):8733-42. PubMed ID: 20056600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-binding domain of endothelial cell thrombospondin: localization to the 70-kDa core fragment and determination of binding characteristics.
    Dardik R; Lahav J
    Biochemistry; 1991 Sep; 30(38):9378-86. PubMed ID: 1716458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An FGF-binding protein (FGF-BP) exerts its biological function by parallel paracrine stimulation of tumor cell and endothelial cell proliferation through FGF-2 release.
    Aigner A; Butscheid M; Kunkel P; Krause E; Lamszus K; Wellstein A; Czubayko F
    Int J Cancer; 2001 May; 92(4):510-7. PubMed ID: 11304685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.